Previous 10 | Next 10 |
Zyla Life Sciences ( OTCQX:ZCOR ): Q2 Net loss of $19.64M. More news on: Zyla Life Sciences, Earnings news and commentary, Healthcare stocks news, , Read more ...
WAYNE, Pa. , Aug. 13, 2019 /PRNewswire/ -- Zyla Life Sciences (OTCQX: ZCOR) ("Zyla"), a commercial-stage life sciences company, today reported financial results for the second quarter ended June 30, 2019 including net sales from commercial products: SPRIX ® (ketorolac...
The attack on opioids is intensifying once again, and the circle of companies falling victim is widening. On Aug. 1, Reuters reported that the State of Oklahoma is now making its final efforts to hold Johnson & Johnson (JNJ) responsible. The Trump Administration has decided to restrict a...
WAYNE, Pa. , July 31, 2019 /PRNewswire/ -- Zyla Life Sciences (OTCQX: ZCOR) ("Zyla"), a commercial-stage life sciences company focused on marketing treatments for different types of pain and inflammation, today announced that its second quarter 2019 financial results will be rel...
NEW YORK , June 24, 2019 /PRNewswire/ -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the June 20 th conference are now available for on-demand viewing at VirtualInvestorConferences.com. RE...
WAYNE, Pa. , June 19, 2019 /PRNewswire/ -- Zyla Life Sciences (OTCQX: ZCOR) ("Zyla"), a growing commercial-stage life sciences company, announced the appointment of Gary M. Phillips , M.D. to its board of directors. "Gary brings to Zyla a wealth of experience from work...
NEW YORK , June 14, 2019 /PRNewswire/ -- Virtual Investor Conferences today announced the agenda for the upcoming Virtual lnvestor Conference, the leading proprietary investor conference series. Individual investors, institutional investors, advisors and analysts are invited to atte...
WAYNE, Pa. , June 12, 2019 /PRNewswire/ -- Zyla Life Sciences (OTCQX:ZCOR) ("Zyla"), a growing commercial-stage life sciences company, announced the appointment of H. Jeffrey Wilkins , M.D. as senior vice president and chief medical officer (CMO) effective immediately. "W...
WAYNE, Pa. , May 16, 2019 /PRNewswire/ -- Egalet Corporation (OTCQX: ZCOR) ("Egalet"), a growing commercial-stage life sciences company, today reported financial results for the first quarter ended March 31, 2019 and announced it will change its name to Zyla Life Sciences ("Zy...
WAYNE, Penn. , May 14, 2019 /PRNewswire/ -- Egalet Corporation (OTCQX: ZCOR) ("Egalet"), a commercial-stage life sciences company focused on marketing treatments for different types of pain and inflammation, today announced that its first quarter 2019 financial results will be r...
News, Short Squeeze, Breakout and More Instantly...
WAYNE, Penn. , May 15, 2020 /PRNewswire/ -- Zyla Life Sciences (OTCQX: ZCOR) ("Zyla" or the "Company"), a commercial-stage life sciences company, today reported financial results for the first quarter ended March 31, 2020 , including net sales from commercial products: SPR...
WAYNE, Pa. , May 1, 2020 /PRNewswire/ -- Zyla Life Sciences (OTCQX: ZCOR) ("Zyla"), a commercial stage life sciences company, today announced that its 2020 first quarter financial results will be released on May 15, 2020 . Following the announcement, Zyla's management will host a li...
Merger with Zyla Life Sciences Expected to Close Shortly After the 2020 Annual Meeting Assertio Reaffirms its Ability to Achieve Upwards of $40 Million in Synergies Will Report First Quarter 2020 Financial Results on Monday, May 11, 2020 Prior to the Open of Markets LAKE ...